Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement On January 20, 2026, Ekso Bionics Holdings, Inc. (the “Company”) entered into securities purchase agreements (collect
Unregistered Sales of Equity Securities The information set forth under Item 1.01 of this Current Report on Form 8-K relating to the Purchase Agreements and War
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. In connection with the Private Placement, on January 22, 2026, the Company filed a Cer
Financial Statements and Exhibits (d) Exhibits Exhibit Description 3.1 Certificate of Designation of Series B Preferred Stock 4.1* Form of Warrant 10.1 Form of